Over its trading history on the NSE and BSE, Aarti Drugs' equity valuation has experienced multi-year cyclical patterns. Exceptional peaks during high-demand pharmaceutical cycles were followed by consolidation phases driven by raw material pricing pressures, global supply chain adjustments, and changing input cost structures.